198 related articles for article (PubMed ID: 18210151)
1. Clinical significance of osteopontin expression in cervical cancer.
Cho H; Hong SW; Oh YJ; Kim MA; Kang ES; Lee JM; Kim SW; Kim SH; Kim JH; Kim YT; Lee K
J Cancer Res Clin Oncol; 2008 Aug; 134(8):909-17. PubMed ID: 18210151
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
Leung DT; Lim PL; Cheung TH; Wong RR; Yim SF; Ng MH; Tam FC; Chung TK; Wong YF
PLoS One; 2016; 11(8):e0160412. PubMed ID: 27494141
[TBL] [Abstract][Full Text] [Related]
3. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma.
Zhang H; Ye QH; Ren N; Zhao L; Wang YF; Wu X; Sun HC; Wang L; Zhang BH; Liu YK; Tang ZY; Qin LX
J Cancer Res Clin Oncol; 2006 Nov; 132(11):709-17. PubMed ID: 16786357
[TBL] [Abstract][Full Text] [Related]
5. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.
Rouanne M; Adam J; Goubar A; Robin A; Ohana C; Louvet E; Cormier J; Mercier O; Dorfmüller P; Fattal S; de Montpreville VT; Lebret T; Dartevelle P; Fadel E; Besse B; Olaussen KA; Auclair C; Soria JC
BMC Cancer; 2016 Jul; 16():483. PubMed ID: 27422280
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of osteopontin expression and laryngeal squamous cell carcinoma infiltration and metastasis].
Zhao Hongchun ; Wang Yanfei ; Zheng Tihua ; Che Juan ; Cao Ruijuan ; Wang Xia
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Sep; 29(17):1530-3. PubMed ID: 26647537
[TBL] [Abstract][Full Text] [Related]
8. Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma.
Cristaudo A; Foddis R; Bonotti A; Simonini S; Vivaldi A; Guglielmi G; Ambrosino N; Canessa PA; Chella A; Lucchi M; Mussi A; Mutti L
Int J Biol Markers; 2010; 25(3):164-70. PubMed ID: 20878622
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of the co-detection of the urokinase plasminogen activator system and osteopontin in patients with non-small-cell lung cancer undergoing radiotherapy and correlation with gross tumor volume.
Ostheimer C; Evers C; Bache M; Reese T; Vordermark D
Strahlenther Onkol; 2018 Jun; 194(6):539-551. PubMed ID: 29340706
[TBL] [Abstract][Full Text] [Related]
10. Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer.
Plumer A; Duan H; Subramaniam S; Lucas FL; Miesfeldt S; Ng AK; Liaw L
BMC Cancer; 2008 Jan; 8():38. PubMed ID: 18237408
[TBL] [Abstract][Full Text] [Related]
11. Elevated content of osteopontin in plasma and tumor tissues of patients with laryngeal and hypopharyngeal carcinoma associated with metastasis and prognosis.
Li Y; Li L; Wang JT; Kan X; Lu JG
Med Oncol; 2012 Sep; 29(3):1429-34. PubMed ID: 21706367
[TBL] [Abstract][Full Text] [Related]
12. Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial.
Bramwell VH; Tuck AB; Chapman JA; Anborgh PH; Postenka CO; Al-Katib W; Shepherd LE; Han L; Wilson CF; Pritchard KI; Pollak MN; Chambers AF
Breast Cancer Res; 2014 Jan; 16(1):R8. PubMed ID: 24451146
[TBL] [Abstract][Full Text] [Related]
13. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.
Blasberg JD; Pass HI; Goparaju CM; Flores RM; Lee S; Donington JS
J Clin Oncol; 2010 Feb; 28(6):936-41. PubMed ID: 20085934
[TBL] [Abstract][Full Text] [Related]
14. Clinical implications of osteopontin in metastatic lesions of uterine cervical cancers.
Sakaguchi H; Fujimoto J; Hong BL; Tamaya T
Cancer Lett; 2007 Mar; 247(1):98-102. PubMed ID: 16675104
[TBL] [Abstract][Full Text] [Related]
15. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.
Vordermark D; Said HM; Katzer A; Kuhnt T; Hänsgen G; Dunst J; Flentje M; Bache M
BMC Cancer; 2006 Aug; 6():207. PubMed ID: 16911785
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of osteopontin in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Sun T; Li P; Sun D; Bu Q; Li G
Medicine (Baltimore); 2018 Oct; 97(43):e12954. PubMed ID: 30412113
[TBL] [Abstract][Full Text] [Related]
17. Serum level of osteopontin as a prognostic factor in patients who underwent surgical resection for non-small-cell lung cancer.
Takenaka M; Hanagiri T; Shinohara S; Yasuda M; Chikaishi Y; Oka S; Shimokawa H; Nagata Y; Nakagawa M; Uramoto H; So T; Yamada S; Tanaka F
Clin Lung Cancer; 2013 May; 14(3):288-94. PubMed ID: 23122494
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of plasma osteopontin in patients with locoregionally advanced head and neck squamous cell carcinoma treated on TROG 02.02 phase III trial.
Lim AM; Rischin D; Fisher R; Cao H; Kwok K; Truong D; McArthur GA; Young RJ; Giaccia A; Peters L; Le QT
Clin Cancer Res; 2012 Jan; 18(1):301-7. PubMed ID: 22096023
[TBL] [Abstract][Full Text] [Related]
20. Perioperative changes in osteopontin and TGFβ1 plasma levels and their prognostic impact for radiotherapy in head and neck cancer.
Polat B; Kaiser P; Wohlleben G; Gehrke T; Scherzad A; Scheich M; Malzahn U; Fischer T; Vordermark D; Flentje M
BMC Cancer; 2017 Jan; 17(1):6. PubMed ID: 28049456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]